IndraLab

Statements


1 | 8

reach
"Simvastatin Reduces RelA and Transiently Increases c-Rel in the Nuclear Fraction of pMCAO Rats."

reach
"Neither quinapril nor simvastatin given for 7 d produced a suppression of ROS generation, intranuclear NF-kappa B, p65, or CRP, and these two agents did not alter cellular I kappa B either."

reach
"As shown in Fig. 2 C, p65 protein turnover increased in simvastatin-treated cells, suggesting a role for protein stabilization in simvastatin-induced p65 down-regulation."

reach
"However, knock-down of SOCS1 abolished simvastatin-induced p65 degradation in the cell nucleus."

reach
"Simvastatin alone or together with amfenac significantly reduced the DNA binding of NF-κB p65 whereas amfenac had no effect (Fig. 3a)."

reach
"Simvastatin therapy also significantly reduced monocytic nuclear factor-kappaB p65 activity, compared with placebo (P < 0.01)."

reach
"The findings that simvastatin-induced p65 down-regulation further reduces MMP-2 expression in SP600125-treated ( Fig. 4 D), c-Jun/ATF-2 siRNA-transfected ( Fig. 4 E) and JNK1 shRNA-transfected ( Fig. [MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]"

reach
"In a previous study, it was reported that simvastatin reduced the nucleolar content of the NFκB-RelA complex while increasing NFκB-cRel combination."